Pelage Pharmaceuticals, Inc., 2025-11-24
An SEC Form D private-offering notice from Los Angeles, CA, a $119,999,987 filer-stated offering target in Biotech. Filed 2025-11-24. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops PP405, a topical small molecule therapy designed to reactivate dormant hair follicle stem cells to treat hair loss.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Goals Program, LLC, 2025-11-24, $500K, Rocklin, CA
- Shunwang International Institute of Medicine & Food Homology Research Ltd, 2025-11-24, $5M, Hong Kong
- Parnassus Labs, Inc., 2025-11-24, $18.6M, San Francisco, CA
- XTRESSE, LLC, 2025-11-24, $10M, Orlando, FL
- Rivington Labs Inc., 2025-11-24, $40M, San Francisco, CA
- Neela Therapeutics, Inc., 2025-11-24, $21.5M, Lunenburg, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.